SLAMF7 and neoplasm: Mice treated with CS1 CAR T cell monotherapy had a delay in tumor growth of 10 days compared to untreated controls (Fig. 1A–B, Fig. S1) and a median survival of 49 days compared to 40 days for untreated controls (Fig. 1C and Table S1).